Member Info for violindog

Sorry you have lost a friend.

Johnny, certainly seams that Covidity is on the right track. Hope it's enough to trigger a deal. Large pharmaceutical companies must have "talent spotters" and be aware of our trial in progress and even the initial positive data.

It would be great to have some blue...
Modi1, for me, has to start in Q1.

Thanks Berm, I was very worried it would be back to square one.

As per the quote below:
Company plans to mitigate by increasing the number of trial sites, widening the patient selection criteria and minimising hospital visits for enrolled patients.

"Widening the patient selection criteria" .... would this require trial approval and starting the trial application from scratch ? Or can it be done as an add on in parrell to existing application?

We were told about the collaboration Jan 2018... after 4 years.... what's happening? either something or nothing but an update would be good.

Nomlungu, great article but I can't see why it would influence SCLPs share price. We don't get a mention and I can't see how the average investor would link the article with SCLP.
If we got an update on the collaboration with BioNtec ... that may help.

Is there anything stopping a pharma asking to look at the data so far on Covidity under a NDA with the potential of making an early deal ?
Would Scancell be better to hold out for a full readout of data ??

Ray, guess it would/ may depend upon what's offered and by whom...bird in hand and all that...

Chester - agree. Re the Modi1 trial start ... from memory the "lead hospital" was in Liverpool ??
It would be interesting to drill down and see the local Covid rates for this area which may give a guide as to the workload at the local hospital.

If it doesn't start in Q1 .....hmm

Chester, has to be modi1 !!

Today was indeed brutal but in line with many,many stocks across the board.

C7, let's hope for a good week ahead. We have all been holding for so many years, so many funding rounds.. and now we are on the home straight for one of our products.
It would be great to see the Modi1 trial underway.

Chester, many thanks.

Chester, can't argue with your analysis. I wonder if Scancell have any data on the first batch of volunteers and if so, could this be released , or would Scancell need to wait until data from all 40.
Guess we may find out next week.

Chelsea11, impossible to say where we are with recruitment. From your link : 4 DNA trials in phase 3 with one already approved. So SCLP won't be the first in the race but I guess its all about the data and how effective Covidity is. Im not the best at the science so my question is ... will Covidity valadate the whole Immunobody platform ?

.... or not so good : (
Further away from £1 than last week ..oh well ..roll on results and with luck we may hopefully get a good boost to the share price.

Hi Guys, Fridays always seam to be kind to Scancell. My dream continues to be £1 per share.

I think autoimmune diseases would fit well with SCLP ( and there has been links with MS I think), but let's get Modi1 off the launch pad first. We have had the count down from LD ... gust need ignition and lift off !!

Improved now ... no longer -4.47 % Up to -2.35%